A Randomized Open-Label Trial of Caspofungin vs. Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)
-
- STATUS
- Not Recruiting
Summary
In this study, researchers want to find out if using a newer antifungal drug called caspofungin (also called Cancidas?) will be better than the current standard antifungal drug fluconazole at preventing invasive fungal infections when given to people with
Description
In this study, researchers want to find out if using a newer antifungal drug called caspofungin (also called Cancidas?) will be better than the current standard antifungal drug fluconazole at preventing invasive fungal infections when given to people with
Details
| Condition | Acute Myeloid Leukemia |
|---|---|
| Age | 18years or below |
| Clinical Study Identifier | TX1968 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.